Anticoagulating the subsegmental pulmonary embolism in cancer patients: a survey amongst different medical specialties

Journal of Thrombosis and Thrombolysis

Volumn 40, Issue 1, 2015, Pages 37-41

  Lim, Wang Yng ^a   Bozas, Georgios ^a   Noble, Simon ^b   Hart, Simon ^a   Maraveyas, Anthony ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Anticoagulation; Cancer; Pulmonary embolism; Subsegmental pulmonary embolism; Survey; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DYSPNEA; ECHOGRAPHY; FATIGUE; FEMALE; HUMAN; LUNG EMBOLISM; LUNG SCINTISCANNING; MALE; MEDICAL DECISION MAKING; ONCOLOGIST; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROGNOSIS; PULMONOLOGIST; TIME TO TREATMENT; TREATMENT DURATION; TREATMENT PLANNING; VENOUS THROMBOEMBOLISM; WORK EXPERIENCE; MEDICINE; NEOPLASMS; PHYSICIAN; PROCEDURES; PULMONARY EMBOLISM; QUESTIONNAIRE;

ANTICOAGULANTS; HUMANS; MEDICINE; NEOPLASMS; PHYSICIANS; PULMONARY EMBOLISM; SURVEYS AND QUESTIONNAIRES; VENOUS THROMBOEMBOLISM;

EID: 84942914586     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-014-1143-9     Document Type: Article

References (24)

1. Nordstrom M, Lindblad B, Anderson H et al (1994) Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 308:891–894
2. Noble S, Pasi J (2010) Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer 102:S2–S9
3. DeMonaco NA, Dang Q, Kapoor WN et al (2008) Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med 121:611–617
4. Dentali F, Ageno W, Becattini C et al (2010) Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res 125:518–522
5. Sebastian AJ, Paddon AJ (2006) Clinically unsuspected pulmonary embolism: an important secondary finding in oncology CT. Clin Radiol 61:81–85
6. Larici AR, Calandriello L, Maggi F et al (2007) Prevalence of incidental pulmonary emboli in oncology patients. Radiology 245:921–922
7. Browne AM, Cronin CG, English C et al (2010) Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol 5:798–803
8. Cronin CG, Lohan DG, Keane M et al (2007) Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. AJR Am J Roentgenol 189:162–170
9. Gladish GW, Choe DH, Marom EM et al (2006) Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology 240:246–255
10. O’Connell CL, Boswell WD, Duddalwar V et al (2006) Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. J Clin Oncol 24:4928–4932
11. Maraveyas A, Johnson M (2009) Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Br J Cancer 100:1837–1841
12. Weiner RS, Schwartz LM, Woloshin S (2013) When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ 347:f3368
13. Lee AY, Levine MN, Baker RI et al (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349:146–153
14. Khorana AA, Francis CW, Culakova E et al (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5:632–634
15. den Exter PL, Hooijer J, Dekkers OM et al (2011) Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 29:2405–2409
16. den Exter PL, Jiménez D, Kroft LJ et al (2012) Outcome of incidentally diagnosed pulmonary embolism in patients with malignancy. Curr Opin Pulm Med 18:399–405
17. National Institute for Health and Care Excellence. Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. London: National Institute for Health and Care Excellence; 2012. http://www.nice.org.uk/guidance/CG144/chapter/introduction. Accessed 9 July 2014
18. Gurney JW (1993) No fooling around: direct visualization of pulmonary embolism. Radiology 188:618–619
19. Ogren M, Bergqvist D, Wahlanden K et al (2006) Trousseau’s syndrome-what is the evidence? A population based autopsy study. Thromb Haemost 95:541–545
20. Bozas G, Bradley RL, Avery G, et al. (2013) Pre-existing pulmonary thrombi in cancer patients diagnosed with an unsuspected pulmonary embolism. In: Reitsma P, Rosendaal F (eds) Proceedings of the XXIV congress of the international society of thrombosis and haemostasis, Wiley-Blackwell, p. 856
21. Carrier M, Kimpton M, Le Gal G et al (2011) The management of a subsegmental pulmonary embolism: a cross-sectional survey of Canadian thrombosis physicians. J Thromb Haemost 9:1412–1415
22. Johnson MJ, Sheard L, Maraveyas A et al (2012) Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study. BMC Med Inf Decis Mak 12:75
23. den Exter PL, van Roosmalen MJ, van den Hoven P et al (2013) Physicians’ management approach to an incidental pulmonary embolism: an international survey. J Thromb Haemost 11:208–213
24. Pesavento R, Casazza F, Filippi L et al (2013) An international survey on isolated subsegmental pulmonary embolism. Thromb Res 131:183–184